37
20WAYS TO IMPROVE PATIENT CARE & PHARMACY PROFITABILITY
FALL 2025 I RETAIL/COMMUNITY • SPECIALTY • LTC
CEO & Chairman
of the Board:
Kevin R. Sayer
President & COO:
Jake Leach
Founded:
1999
Employees:
>8,000 globally
Stock Symbol:
DXCM
Toll-Free Phone:
(888) 738-3646
Website:
Dexcom.com
Company Background
Dexcom, Inc. empowers people to take control of health through
innovative CGM systems. Headquartered in San Diego, California,
Dexcom has emerged as a leader of diabetes care technology. By listening
to the needs of users, caregivers, and providers, Dexcom simplifies and
improves diabetes management around the world.
Product Overview
Dexcom G7 is the simple CGM for effortless diabetes management.
Users will receive real-time glucose readings automatically on their
compatible smart device§ or Dexcom receiver, no fingersticks|| required.
Dexcom G7 also offers a suite of customizable alerts that can warn of
high or low glucose levels with a predictive low alert that can recognize
potentially dangerous hypoglycemic incidents before they occur.
Dexcom CGM has demonstrated a >1% A1C reduction after 12
weeks.1,2,5 Dexcom G7 can help patients reach their glycemic goals and
improve their quality of life.1-5,10 Dexcom G7 is a preferred CGM of
national payors on the pharmacy benefit.7,¶ As the most covered CGM
brand,7,# Dexcom requires only one prescription for Dexcom G7 to
be sent directly to the pharmacy for a quick, simple start and low out-
of-pocket costs. Most covered patients pay $20 or less per month for
Dexcom CGM.11,**
Dexcom G7 is an integrated CGM (iCGM) indicated for the widest age
range and across diabetes types (type 1, type 2, and gestational diabetes)
and treatment types (basal insulin, noninsulin, glucagon-like peptide-1).
No other CGM system is more affordable than Dexcom G7 for Medicare
patients.†† For more information on affordability programs, please visit
dexcom.com/savings.
Features & Options
n Dexcom G7 is the most connected CGM system7:
• The first and only iCGM brand that allows for Share and Follow while
also using an automated insulin delivery (AID)-connected system.‡‡
• The first and only CGM with no fingersticks from day 1.||
• Only CGM with app features that help protect from severe
hypoglycemia and diabetic ketoacidosis.12
• 1.7 million customer years and growing of powering AID systems.7
• Dexcom G7 is the most connected CGM,7 connecting to Tandem,
Lily Tempo, Insulet Omnipod, and Beta Bionics devices.
Testimonials
n Dexcom is the most affordable CGM brand at the pharmacy11,§§:
• Dexcom is the #1 recommended CGM system by patients.13,†
• 96% of patients say Dexcom G7 is easy to use.14
• Dexcom ranks #1 in patient satisfaction,† adherence, and retention.7-9,‡
• Dexcom is a preferred CGM of national payors on the
pharmacy benefit.7,¶
• 98% of people have coverage for Dexcom G7.7,§§ ,||||
• 75% of Medicare Advantage lives have coverage for Dexcom G7 at
the pharmacy.11 Savings programs are available for patients without
CGM coverage.
Ordering Information
To order, please contact your pharmacy wholesale partner. Dexcom G7
is available to order from all major wholesalers.
*Compared to self-monitoring of blood glucose.
†Based on a comparison in net promoter scores across major CGM brands.
‡IQVIA paid sensor claims at 12 months.
§Smart devices sold separately. For a list of compatible devices, visit dexcom.com/compatibility.
||Fingersticks required for diabetes treatment decisions if symptoms or expectations do not
match readings.
¶Individual coverage may vary depending on commercial pharmacy coverage benefits.
#Individual coverage may vary depending on insurance plan.
**Individual pricing may vary depending on insurance coverage. IQVIA FIA retail data, paid
sensor claims.
††Under Medicare’s durable medical equipment (DME) fee schedule, reimbursement and coinsurance for
CGM using Current Procedural Terminology (CPT) codes A4239 and E2103 are the same, regardless of
CGM brand.
‡‡Internet connection and separate Follow app required. To view compatibility, visit dexcom.com/compatibility.
§§Individual pricing may vary depending on insurance coverage.
||||Includes both pharmacy and medical benefit.
1 Beck RW, et al. JAMA. 2017;317(4):371-378. 2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
3 Martens T, et al. JAMA. 2021;325(22):2262-2272. 4 Laffel LM, et al. JAMA. 2020;323(23):2388-
2396. 5 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-147. 6 Garg SK, et al. Diabetes Technol Ther.
2025. doi:10.1089/dia.2025.0139 Epub ahead of print. 7 Dexcom, data on file, 2024. 8 dQ&A Q1
2023 Patient Perspectives. 9 Seagrove Patient Perspectives 2024. 10 Gilbert TR, et al. Diabetes Technol
Ther. 2021;23(S1):S35-S39. 11 Dexcom, data on file, 2025. 12 Graham R, et al. Diabetes Technol Ther.
2024;26(1):24-32. 13 Seagrove Patient Survey 2024. 14 Dexcom G7 CGM System User Guide.
Dexcom Continuous Glucose Monitoring (CGM) is proven to lower
A1C and increase time in range.1-3,5,6 Dexcom ranks #1 in patient
satisfaction,† adherence, and retention.7-9,‡
Dexcom CGM — Empowering
Unmatched Glucose Control1-5,*